InVivoScribe Technologies Inc:企業の製品パイプライン分析

◆英語タイトル:InVivoScribe Technologies Inc - Product Pipeline Analysis, 2020 Update
◆商品コード:GDME214897PD
◆発行会社(調査会社):GlobalData
◆発行日:2021年1月
◆ページ数:37
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD1,500 ⇒換算¥162,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥243,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
InVivoScribe Technologies Inc (InVivoScribe) is a provider of hematology-oncology testing products and services. The company offer full range of hematology-oncology testing products and services. It’s products include lymphotrack and lymphotrack DX assay kits, and custom assay and reagent development products. InVivoScribe also provides general purpose reagents such as PCR and cDNA reagents, gel detection reagents and ABI fluorescence detection reagents. The company offers PCR-based gene rearrangement, chromosome translocation, and gene mutation research use only testing reagents and controls. It provides its in vitro diagnostic cGMP products for hematology-oncology, RUO assays, analyte specific reagents, and DNA and RNA controls. The company operates through research laboratories located in Japan. InVivoScribe is headquartered in San Diego, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company InVivoScribe Technologies Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
InVivoScribe Technologies Inc Company Overview
InVivoScribe Technologies Inc Company Snapshot
InVivoScribe Technologies Inc Pipeline Products and Ongoing Clinical Trials Overview
InVivoScribe Technologies Inc – Pipeline Analysis Overview
InVivoScribe Technologies Inc – Key Facts
InVivoScribe Technologies Inc – Major Products and Services
InVivoScribe Technologies Inc Pipeline Products by Development Stage
InVivoScribe Technologies Inc Ongoing Clinical Trials by Trial Status
InVivoScribe Technologies Inc Pipeline Products Overview
B-cell Clonality Assay Kit
B-cell Clonality Assay Kit Product Overview
B-cell Immuno-Oncology Assay Kit
B-cell Immuno-Oncology Assay Kit Product Overview
Companion Diagnostic Test – Eprenetapopt
Companion Diagnostic Test – Eprenetapopt Product Overview
LeukoStrat CDx FLT3 Mutation Assay – Gilteritinib Fumarate
LeukoStrat CDx FLT3 Mutation Assay – Gilteritinib Fumarate Product Overview
LeukoStrat CDx FLT3 Mutation Assay – Quizartinib
LeukoStrat CDx FLT3 Mutation Assay – Quizartinib Product Overview
LeukoStrat CDx FLT3 Mutation Assay – Quizartinib Clinical Trial
LymphoTrack Dx TRB Assay – PGM
LymphoTrack Dx TRB Assay – PGM Product Overview
MiSeqDx – Cancer Diagnostic Test
MiSeqDx – Cancer Diagnostic Test Product Overview
NGS Based Hematologic Malignancy Test
NGS Based Hematologic Malignancy Test Product Overview
T-cell Clonality Assay Kit
T-cell Clonality Assay Kit Product Overview
T-cell Immuno-Oncology Assay Kit
T-cell Immuno-Oncology Assay Kit Product Overview
InVivoScribe Technologies Inc – Key Competitors
InVivoScribe Technologies Inc – Key Employees
InVivoScribe Technologies Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
InVivoScribe Technologies Inc, Recent Developments
Oct 30, 2019: European Commission approves Astellas’ XOSPATA for patients with relapsed or refractory Acute Myeloid Leukemia with mutations detected using Invivoscribe’s LeukoStrat CDx FLT3 Mutation Assay
Jun 19, 2019: Japan’s MHLW approves Invivoscribe’s LeukoStrat CDx FLT3 Mutation Assay as the CDx for Daiichi Sankyo’s Quizartinib for treatment of Relapsed/Refractory FLT3-ITD AML. Expands use to include specimens collected in EDTA
Jun 03, 2019: Invivoscribe to exhibit at ASCO 2019
May 21, 2019: Invivoscribe Expanding Clinical Laboratory Network Space and Testing Capabilities in San Diego, Germany, Japan, and China
Jan 23, 2019: Invivoscribe LymphoTrack Dx Assays now available
Jan 03, 2019: Invivoscribe to present at biotech showcase 2019 in San Francisco
Nov 29, 2018: US FDA approves Invivoscribe LeukoStrat CDx FLT3 Mutation Assay as CDx and Astellas drug XOSPATA (gilteritinib fumarate) for treatment of AML patients in the US
Nov 27, 2018: Invivoscribe submits LeukoStrat CDx FLT3 Mutation Assay both in the US and Japan to support Daiichi Sankyo submissions for Quizartinib
Nov 19, 2018: Invivoscribe submits the LeukoStrat CDx FLT3 Mutation Assay to support Daiichi Sankyo submission for Quizartinib in Japan
Sep 28, 2018: Invivoscribe receives approval in Japan for its LeukoStrat CDx FLT3 Mutation Assay for the assessment of acute myeloid leukemia (AML) patients treated with Xospata (gilteritinib fumarate)
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
InVivoScribe Technologies Inc Pipeline Products and Ongoing Clinical Trials Overview
InVivoScribe Technologies Inc Pipeline Products by Equipment Type
InVivoScribe Technologies Inc Pipeline Products by Indication
InVivoScribe Technologies Inc Ongoing Clinical Trials by Trial Status
InVivoScribe Technologies Inc, Key Facts
InVivoScribe Technologies Inc, Major Products and Services
InVivoScribe Technologies Inc Number of Pipeline Products by Development Stage
InVivoScribe Technologies Inc Pipeline Products Summary by Development Stage
InVivoScribe Technologies Inc Ongoing Clinical Trials by Trial Status
InVivoScribe Technologies Inc Ongoing Clinical Trials Summary
B-cell Clonality Assay Kit - Product Status
B-cell Clonality Assay Kit - Product Description
B-cell Immuno-Oncology Assay Kit - Product Status
B-cell Immuno-Oncology Assay Kit - Product Description
Companion Diagnostic Test - Eprenetapopt - Product Status
Companion Diagnostic Test - Eprenetapopt - Product Description
LeukoStrat CDx FLT3 Mutation Assay - Gilteritinib Fumarate - Product Status
LeukoStrat CDx FLT3 Mutation Assay - Gilteritinib Fumarate - Product Description
LeukoStrat CDx FLT3 Mutation Assay - Quizartinib - Product Status
LeukoStrat CDx FLT3 Mutation Assay - Quizartinib - Product Description
LeukoStrat CDx FLT3 Mutation Assay - Quizartinib - A Phase 3 Open-label Randomized Study of Quizartinib (AC220) Monotherapy Versus Salvage Chemotherapy in Subjects with Tyrosine Kinase 3 - Internal Tandem Duplication (FLT3-ITD) Positive Acute Myeloid Leukemia (AML) Refractory to or Relapsed after First-line Treatment with or without Hematopoietic Stem Cell Transplantation (HSCT) Consolidation
LymphoTrack Dx TRB Assay - PGM - Product Status
LymphoTrack Dx TRB Assay - PGM - Product Description
MiSeqDx - Cancer Diagnostic Test - Product Status
MiSeqDx - Cancer Diagnostic Test - Product Description
NGS Based Hematologic Malignancy Test - Product Status
NGS Based Hematologic Malignancy Test - Product Description
T-cell Clonality Assay Kit - Product Status
T-cell Clonality Assay Kit - Product Description
T-cell Immuno-Oncology Assay Kit - Product Status
T-cell Immuno-Oncology Assay Kit - Product Description
InVivoScribe Technologies Inc, Key Employees
InVivoScribe Technologies Inc, Subsidiaries
Glossary

★海外企業調査レポート[InVivoScribe Technologies Inc:企業の製品パイプライン分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • JB Hi-Fi Limited (JBH):企業の財務・戦略的SWOT分析
    JB Hi-Fi Limited (JBH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Banco Occidental de Descuento:企業の戦略・SWOT・財務分析
    Banco Occidental de Descuento - Strategy, SWOT and Corporate Finance Report Summary Banco Occidental de Descuento - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • The Shanghai Commercial & Savings Bank Ltd:企業の戦略・SWOT・財務情報
    The Shanghai Commercial & Savings Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary The Shanghai Commercial & Savings Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • IXYS, LLC:企業の戦略的SWOT分析
    IXYS, LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Sky plc:企業の戦略・SWOT・財務分析
    Sky plc - Strategy, SWOT and Corporate Finance Report Summary Sky plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Ruth’s Hospitality Group, Inc.:企業の戦略・SWOT・財務情報
    Ruth's Hospitality Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Ruth's Hospitality Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Perrigo Company Plc (PRGO):医療機器:M&Aディール及び事業提携情報
    Summary Perrigo Company plc (Perrigo) is an over-the-counter consumer goods and specialty pharmaceutical company. It develops, manufactures and distributes over-the-counter products, generic and prescription pharmaceuticals, specialty pharmaceutical company, nutritional products, active pharmaceutic …
  • Hermes International SA:企業の戦略・SWOT・財務情報
    Hermes International SA - Strategy, SWOT and Corporate Finance Report Summary Hermes International SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Grupo Nutresa SA (NUTRESA):企業の財務・戦略的SWOT分析
    Grupo Nutresa SA (NUTRESA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Adani Enterprises Ltd (ADANIENT):石油・ガス:M&Aディール及び事業提携情報
    Summary Adani Enterprises Ltd (Adani) is a diversified company with operations in resources, logistics and energy. It has interests in various businesses such as coal trading and mining, bunkering, renewable power generation, defense and aerospace, ports and special economic zones (SEZ), logistics, …
  • The Ensign Group Inc (ENSG):企業の財務・戦略的SWOT分析
    The Ensign Group Inc (ENSG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Zhejiang Hisoar Pharmaceutical Co Ltd (002099):製薬・医療:M&Aディール及び事業提携情報
    Summary Zhejiang Hisoar Pharmaceutical Co Ltd (Hisoar) is a pharmaceutical company that offers specialty raw materials, preparations, fine chemicals, dyes and intermediates. The company offers raw drugs such as antibody, anti-virus, sugar-reducing, cardiovascular and worm-driven drugs. It produces f …
  • Magellan Health, Inc.:企業の戦略・SWOT・財務分析
    Magellan Health, Inc. - Strategy, SWOT and Corporate Finance Report Summary Magellan Health, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Carlisle Companies Incorporated:戦略・SWOT・企業財務分析
    Carlisle Companies Incorporated - Strategy, SWOT and Corporate Finance Report Summary Carlisle Companies Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Showa Shell Sekiyu K.K.:企業の戦略・SWOT・財務情報
    Showa Shell Sekiyu K.K. - Strategy, SWOT and Corporate Finance Report Summary Showa Shell Sekiyu K.K. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Century Aluminum Co:企業の戦略・SWOT・財務分析
    Century Aluminum Co - Strategy, SWOT and Corporate Finance Report Summary Century Aluminum Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • ObsEva SA (OBSV):企業の財務・戦略的SWOT分析
    ObsEva SA (OBSV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Apexigen Inc-製薬・医療分野:企業M&A・提携分析
    Summary Apexigen Inc (Apexigen) is a clinical-stage biopharmaceutical company t hat focuses on discovery and development of antibody-based drugs for the treatment of cancer.The company’s lead immune oncology program APX005M, is a humanized monoclonal antibody that stimulates cancer specific T-cell r …
  • Dubai Electricity and Water Authority:発電所・企業SWOT分析
    Dubai Electricity and Water Authority - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, informatio …
  • The Siam Cement Public Co Ltd:企業の戦略・SWOT・財務分析
    The Siam Cement Public Co Ltd - Strategy, SWOT and Corporate Finance Report Summary The Siam Cement Public Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆